Experiment: 2RVF

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
2	2D 1H-13C HSQC	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
3	3D HNCO	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
4	3D HN(CA)CO	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
5	3D HNCA	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
6	3D HN(CO)CA	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
7	3D HNCACB	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
8	3D CBCA(CO)NH	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
9	3D HBHA(CO)NH	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
10	3D C(CO)NH	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
11	3D HCCH-TOCSY	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
12	3D HCCH-COSY	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
13	2D (HB)CB(CGCD)HD	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
14	3D 1H-15N NOESY	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298
15	3D 1H-13C NOESY	1.1 mM [U-13C; U-15N] crka1 SH2 domain-1, 20 mM [U-2H] TRIS-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 1 mM [U-2H] DTT-5, 10 % [U-2H] D2O-6	90% H2O/10% D2O	120	7.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
torsion angle dynamics, molecular dynamics		XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	21
Representative Model	1 (minimized average structure)

Additional NMR Experimental Information
Details	THE FIRST MODEL 1 IS THE ENERGY-MINIMIZED MEAN STRUCTURE CALCULATED FROM THE OTHER 20 STRUCTURES.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	XwinNMR	3.6	Bruker Biospin
2	collection	TopSpin	2.1	Bruker Biospin
3	processing	NMRPipe	20110801	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	data analysis	NMRView	5.2.2_01	Johnson, One Moon Scientific
5	data analysis	KUJIRA	0.9843	Kobayashi, Iwahara, Koshiba, Tomizawa, Tochio, G ntert, Kigawa, Yokoyama
6	chemical shift assignment	KUJIRA	0.9843	Kobayashi, Iwahara, Koshiba, Tomizawa, Tochio, G ntert, Kigawa, Yokoyama
7	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
8	refinement	Amber	9	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollman
9	refinement	CYANA

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.